Prime Medicine Inc (PRME)

R&D Expenses

$33.40M

Quarterly · Period ending: · USD

PRME logo

PRME R&D Expenses

Latest reported$33.40M
PRME Quarterly R&D Expenses ($920.00K → $33.40M)
High-resolution chart · PNG

PRME r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Prime Medicine Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
33,397,000
34,105,000
34,709,000
43,990,000
41,375,000
40,562,000
34,104,000
40,340,000
43,071,000
37,774,000
41,459,000
40,967,000
34,599,000
30,880,000
29,061,000
25,047,000
18,940,000
13,677,000
52,889,000
7,400,000
5,695,000
4,566,000
1,259,000
920,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.